GLP-1 Agonists Liraglutide Improved Vascular Endothelial Function in Type 2 Diabetes Rats
Liraglutide as additional treatment for type 1 diabetes in: European Journal of Endocrinology Volume 165 Issue 1 (2011)
Liraglutide doesn't affect gastric emptying in type 1 diabetes
Liraglutide With Insulin Improves Glycemic Control in Type 1 Diabetes, Without More Hypoglycemia
Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes, the ADJUNCT ONE™ treat-to-target randomised trial - Media Centre | EASD
a and b, Continuous glucose sensor of a 35-year-old patient with type 1... | Download Scientific Diagram
PDF) Addition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks
Efficacy and safety of liraglutide in type 1 diabetes by baseline characteristics in the ADJUNCT ONE and ADJUNCT TWO randomized controlled trials - Dejgaard - 2021 - Diabetes, Obesity and Metabolism - Wiley Online Library
Victoza Reduces Body Fat, Increases Time in Range in Overweight Adults With Type 1 - DSM
Current and future therapies for type 1 diabetes | SpringerLink
Liraglutide as additional treatment for type 1 diabetes in: European Journal of Endocrinology Volume 165 Issue 1 (2011)
Victoza may benefit patients with type 1 diabetes, review suggests - Diabetes
Liraglutide in Adults with Type 2 Diabetes: Global Perspective on Safety, Efficacy and Patient Preference - Daisuke Yabe, Yutaka Seino, 2011
Diabetes mellitus Typ 1: Add-on-Therapie zu Insulin im Blick
Victoza for People with Type 1 Diabetes?
OP 01 Individualising the choice among GLP-1 receptor agonists - Media Centre | EASD
Frontiers | Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients With Type 1 Diabetes: A Network Meta-Analysis
Disappointing results for liraglutide in type 1 diabetes
Pharmaceuticals | Free Full-Text | Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
Liraglutide Achieves A1C Targets More often than Sitagliptin or Exenatide when Added to Metformin in Patients with Type 2 Diabetes and a Baseline A1C <8.0% - Endocrine Practice
Liraglutide as add-on to insulin therapy reduces BMI, added sugar intake in obese type 1
Real-world effectiveness of liraglutide versus dulaglutide in Japanese patients with type 2 diabetes: a retrospective study | Scientific Reports
One-year effects of liraglutide on pancreatic beta cell function and glycaemic control in Japanese type 1 diabetes with residual insulin secretion - Media Centre | EASD
Comparison Of The Long-Term Effects Of Liraglutide And Glimepiride Monotherapy On Bone Mineral Density In Patients With Type 2 Diabetes - Endocrine Practice
Liraglutide: A New Player in Type 1 Diabetes Treatment?
Full article: Liraglutide for treating type 1 diabetes
